期刊文献+

HPLC-MS/MS法测定儿童微量血浆中白消安和甲氨蝶呤的浓度

Determination of busulfan and methotrexate in children with small volume of plasma by HPLC-MS/MS
下载PDF
导出
摘要 目的建立高效液相色谱串联质谱(HPLC-MS/MS)法测定血浆中白消安和甲氨蝶呤的浓度,并用于儿童血液病患者的治疗药物监测。方法血浆样本经甲醇沉淀蛋白前处理,采用Phenomenex Kinetex EVO C18色谱柱分离,流动相为水(含2 mmol·L^(-1)乙酸铵+0.07%甲酸)和甲醇,梯度洗脱;流速为0.5 mL·min^(-1)。质谱检测方式为电喷雾离子源正离子模式,多反应监测(MRM)扫描,监测离子对:白消安m/z 264.1→151.0、内标白消安-D8 m/z 272.0→159.0;甲氨蝶呤m/z 455.1→m/z 308.2、甲氨蝶呤-D3(内标)m/z 458.1→m/z 311.1。结果白消安在62.50~4000 ng·mL^(-1)内与峰面积线性关系良好(r=0.9984),甲氨蝶呤在15.63~1000 ng·mL^(-1)与峰面积线性关系良好(r=0.9990)。准确度、精密度、基质效应和稳定性均符合要求。结论本方法操作简便、快速准确、专属性强且稳定性好,适用于血浆中白消安和甲氨蝶呤的快速分析,可用于儿童血液肿瘤患者的临床治疗药物监测。 Objective To develop a high performance liquid chromatography-tandem mass spectrometry(HPLC-MS/MS)to determine busulfan and methotrexate in the plasma and monitor the therapeutic drugs in children with hematological disease.Methods The plasma samples were pretreated by protein precipition by methanol.The analytes were eluted on Phenomenex Kinetex EVO C18 column with the mobile phase consisting of water(2 mmol·L^(-1)ammonium acetate+0.07%formic acid)-methanol at the flow rate of 0.5 mL·min^(-1).Ions monitored in the multiple reaction monitoring(MRM)mode were m/z 264.1→151.0 for busulfan,m/z 272.0→159.0 for busulfan-D8(internal standard),m/z 455.1→308.2 for methotrexate,and m/z 458.1→311.1 for methotrexate-D3(internal standard).Results Calibration plots were established at the concentration range of 62.50~4000 ng·mL^(-1)for busulfan(r=0.9984)and 15.63~1000 ng·mL^(-1)for methotrexate(r=0.9990).Accuracy,precision,matrix effect and stability all met the requirements.Conclusion The method is simple,rapid and suitable for therapeutic drug monitoring of busulfan and methotrexate in the plasma of pediatric patients with neoplastic hematological disorder.
作者 韩玥 秦亚彬 韩雨 丁维靖 张古英 赵宜乐 HAN Yue;QIN Ya-bin;HAN Yu;DING Wei-jing;ZHANG Gu-ying;ZHAO Yi-le(Department of Pharmacy,Hebei Children’s Hospital,Shijiazhuang 050031)
出处 《中南药学》 CAS 2024年第10期2628-2632,共5页 Central South Pharmacy
基金 河北省政府资助临床医学优秀人才项目(No.ZF2023205)。
关键词 白消安 甲氨蝶呤 HPLC-MS/MS 治疗药物监测 busulfan methotrexate HPLC-MS/MS therapeutic drug monitoring
  • 相关文献

参考文献9

二级参考文献70

  • 1王玲玲,宗国军,高嵩,胡应和.柱前衍生高效液相色谱法测定注射液中白消安的研究[J].分析试验室,2006,25(6):18-20. 被引量:3
  • 2张善堂,方焱,屈建,陈象青,沈爱宗,孙言才.柱前衍生高效液相色谱法测定人血浆中白消安的浓度[J].中国医院药学杂志,2007,27(4):458-461. 被引量:16
  • 3Hassan BM,Ljungman P,Bolme P,et al.Busulfan bioavailability[J].Blood,1994,84(7):2144-2150.
  • 4McCune JS,Gibbs JP,Slattery JT.Plasma concentration monitoring of busulfan.does it improve clinical outcome?[J].Clin Pharmacokinet,2000,39(2):155-164.
  • 5Chen TL,Grochow LB,Hurowitz LA,et al.Determination of busulfan in human plasma by gas chromatography with electron-capture detection[J].J Chromatogr,1988,425:303-309.
  • 6Rifai N,Sakamoto M,Lafi M,et al.Measurement of plasma busulfan concentration by high-performance liquid chromatography with ultraviolet detection[J].Ther Drug Monit,1997,19:169-174.
  • 7Henner WD,Furlong EA,Flaherty MD,et al.Measurement of busulfan in plasma by high-performance liquid chromatography[J].J Chromatogr B,1987,416;426-432.
  • 8Dos Reis FO,Vianna-Jorge R,Suarez-Kurtz G,et al.Development of a rapid and specific assay for detection of busulfan in human plasma by high-performance liquid chromatography/electrospray ionization tandem mass spectrometry[J].Rapid Commun Mass Spectrom,2005,19:1666-1674.
  • 9Kellogg MD,Law T,Sakamoto M,et al.Tandem mass spectrometry method for the quantification of serum busulfan[J].Ther Drug Monit,2005,27(5):625-629.
  • 10Auh M,Stachel D,Kuhlen M,et al.Quantification of busulfan in saliva and plasma in haematopoietic stem cell transplantation in children:validation of liquid chromatography tandem mass spectrometry method[J].Clin Pharmacokinet,2006,45 (3):305-316.

共引文献75

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部